In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its shortage list.
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly's blockbuster weight loss and diabetes drugs.
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, Mounjaro and Zepbound, after the FDA declares the tirzepatide shortage resolved.
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss drugs during widespread shortages to halt production now that supplies are stabilizing.
Compounding group sues FDA for removing Lilly's weight loss drug from shortage list
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s blockbuster weight loss and diabetes drugs off its list of medicines in short supply last week.
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
WW surge after GLP-1 compounding announcement not justified after study, Barclays says
A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...
aha.org12h
FDA Issues Guidance for Compounding Certain Drug Products in Response to IV Solutions Supply Disruption
The Food and Drug Administration (FDA) today released guidance that is effective immediately for compounding certain parenteral drug products in response to the effects of recent hurricanes, including ...
Rivals fight for right to sell weight loss drugs
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...
Want a Decade of Growing Passive Income? Buy This Dividend Growth Stock and Never Sell.
Perhaps the perfect dividend growth stock is Lockheed Martin ( LMT 1.12%). The aerospace and defense contractor has grown its ...
Connecticut Post1d
More cities are getting hit by back-to-back disasters, which complicates everything from insurance to rebuilding
A recent National Academies consensus study I worked on looked into the compounding disasters that the region faced – both physical and socioeconomic – as storm after storm arrived during the ...
SharkNinja: A Compounding Machine With Strong Competitive Advantages
SharkNinja offers cleaning, food preparation, and all appliances for home, indoors, and outdoors. See what makes SN stock a ...
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
Why the First $1 Million Is the Hardest
One reason why the first $1 million is the hardest is because it's hard to get started—and another is that the power of ...